2024-20896. Medical Devices; Immunology and Microbiology Devices; Classification of the Device To Detect or Measure Nucleic Acid From Viruses Associated With Head and Neck Cancers
Table 1—Device To Detect or Measure Nucleic Acid From Viruses Associated With Head and Neck Cancers Risks and Mitigation Measures
Identified risks to health Mitigation measures False test results Use of certain specimen collection and transport devices; Certain labeling information; and Certain design verification and validation. Failure to correctly interpret the test results Certain labeling information.
Document Information
- Effective Date:
- 9/16/2024
- Published:
- 09/16/2024
- Department:
- Food and Drug Administration
- Entry Type:
- Rule
- Action:
- Final amendment; final order.
- Document Number:
- 2024-20896
- Dates:
- This order is effective September 16, 2024. The classification was applicable on May 11, 2020.
- Pages:
- 75491-75493 (3 pages)
- Docket Numbers:
- Docket No. FDA-2024-N-4061
- Topics:
- Biologics, Laboratories, Medical devices
- PDF File:
- 2024-20896.pdf
- CFR: (1)
- 21 CFR 866